GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Promimic AB (OSTO:PRO) » Definitions » Debt-to-Revenue

Promimic AB (OSTO:PRO) Debt-to-Revenue : 0.00 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Promimic AB Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Promimic AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.00 Mil. Promimic AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr0.00 Mil. Promimic AB's annualized Revenue for the quarter that ended in Mar. 2024 was kr34.62 Mil. Promimic AB's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.00.


Promimic AB Debt-to-Revenue Historical Data

The historical data trend for Promimic AB's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Promimic AB Debt-to-Revenue Chart

Promimic AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
0.15 0.11 0.29 - -

Promimic AB Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Promimic AB's Debt-to-Revenue

For the Medical Devices subindustry, Promimic AB's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Promimic AB's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Promimic AB's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Promimic AB's Debt-to-Revenue falls into.



Promimic AB Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Promimic AB's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Promimic AB's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


Promimic AB Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Promimic AB's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Promimic AB (OSTO:PRO) Business Description

Traded in Other Exchanges
Address
c/o AstraZeneca R&D Mölndal, AZ BioVentureHub, Molndal, SWE, 431 83
Promimic AB is a biomaterial company producing a nano-thin surface for all implant materials for faster osseointegration.